Evaluation of Treatment Thresholds for Unconjugated Hyperbilirubinemia in Preterm Infants: Effects on Serum Bilirubin and on Hearing Loss?

被引:11
|
作者
Hulzebos, Christian V. [1 ]
van Dommelen, Paula [2 ]
Verkerk, Paul H. [2 ]
Dijk, Peter H. [1 ]
Van Straaten, Henrica L. M. [3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, Div Neonatol, Groningen, Netherlands
[2] TNO, Dept Behav & Societal Sci, Leiden, Netherlands
[3] Isala Clin Zwolle, Dept Pediat, Div Neonatol, Zwolle, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 05期
关键词
LOW-BIRTH-WEIGHT; BRAIN-STEM RESPONSE; VS. CONSERVATIVE PHOTOTHERAPY; UNBOUND BILIRUBIN; NEURODEVELOPMENTAL OUTCOMES; RISK-FACTORS; ASSOCIATION;
D O I
10.1371/journal.pone.0062858
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Severe unconjugated hyperbilirubinemia may cause deafness. In the Netherlands, 25% lower total serum bilirubin (TSB) treatment thresholds were recently implemented for preterm infants. Objective: To determine the rate of hearing loss in jaundiced preterms treated at high or at low TSB thresholds. Design/Methods: In this retrospective study conducted at two neonatal intensive care units in the Netherlands, we included preterms (gestational age <32 weeks) treated for unconjugated hyperbilirubinemia at high or low TSB thresholds. Infants with major congenital malformations, syndromes, chromosomal abnormalities or toxoplasmosis, rubella, cytomegalovirus, herpes, syphilis, and human immunodeficiency infections were excluded. We analyzed clinical characteristics and TSB levels during the first ten postnatal days. After two failed automated Auditory Brainstem Response (ABR) tests we used the results of the diagnostic ABR examination to define normal, unilateral, and bilateral hearing loss (>35 dB). Results: There were 479 patients in the high and 144 in the low threshold group. Both groups had similar gestational ages (29.5 weeks) and birth weights (1300 g). Mean and mean peak TSB levels were significantly lower after the implementation of the novel thresholds: 152 +/- 43 mu mol/L and 212 +/- 52 mu mol/L versus 131 +/- 37 mu mol/L and 188 +/- 46 mu mol/L for the high versus low thresholds, respectively (P<0.001). The incidence of hearing loss was 2.7% (13/479) in the high and 0.7% (1/144) in the low TSB threshold group (NNT = 50, 95% CI, 25-3302). Conclusions: Implementation of lower treatment thresholds resulted in reduced mean and peak TSB levels. The incidence of hearing impairment in preterms with a gestational age <32 weeks treated at low TSB thresholds was substantially lower compared to preterms treated at high TSB thresholds. Further research with larger sample sizes and power is needed to determine if this effect is statistically significant.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Evaluation of hearing loss in patients with neonatal unconjugated hyperbilirubinemia
    Korkmaz, Baki
    San, Imran
    Kar, Murat
    Iynen, Ismail
    [J]. ENT UPDATES, 2013, 3 (02): : 45 - 50
  • [2] Unconjugated free bilirubin in preterm infants
    van der Schoor, Lori W. E.
    Dijk, Peter H.
    Verkade, Henkjan J.
    Kamsma, Anna C. J.
    Schreuder, Andrea B.
    Groen, Henk
    Hulzebos, Christian V.
    [J]. EARLY HUMAN DEVELOPMENT, 2017, 106 : 25 - 32
  • [3] Bilirubin Albumin Binding and Unbound Unconjugated Hyperbilirubinemia in Premature Infants
    Amin, Sanjiv B.
    Wang, Hongyue
    [J]. JOURNAL OF PEDIATRICS, 2018, 192 : 47 - 52
  • [4] Dutch thresholds for unconjugated hyperbilirubinemia in pre term infants: when should treatment be started?
    van Imhoff, D. E.
    Dijk, P. H.
    Bos, A. F.
    Hulzebos, C. V.
    [J]. ACTA PAEDIATRICA, 2007, 96 : 197 - 197
  • [5] Treatment of unconjugated hyperbilirubinemia in Gunn rats: Effects of orlistat and phototherapy on bilirubin turnover
    Hafkamp, AM
    Havinga, R
    Pascolo, L
    Tiribelli, C
    Ostrow, JD
    Verkade, HJ
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A756 - A756
  • [6] Improving Evaluation and Treatment of Hyperbilirubinemia in Late Preterm Infants
    Brown, Sheila A.
    Waldrop, Julee
    D'Auria, Jennifer
    Haushalter, Jamie
    [J]. JOURNAL OF PERINATAL & NEONATAL NURSING, 2020, 34 (04) : 346 - 351
  • [7] Uniform treatment thresholds for hyperbilirubinemia in preterm infants: Background and synopsis of a national guideline
    van Imhoff, Deirdre Elisabeth
    Dijk, Peter Hendrik
    Hulzebos, Christian Victor
    [J]. EARLY HUMAN DEVELOPMENT, 2011, 87 (08) : 521 - 525
  • [8] SERUM BILIRUBIN FRACTIONS IN HEALTHY-SUBJECTS AND PATIENTS WITH UNCONJUGATED HYPERBILIRUBINEMIA
    ADACHI, Y
    KATOH, H
    FUCHI, I
    YAMAMOTO, T
    [J]. CLINICAL BIOCHEMISTRY, 1990, 23 (03) : 247 - 251
  • [9] Bilirubin-Displacing Effect of Ceftriaxone in Infants With Unconjugated Hyperbilirubinemia Born at Term
    Amin, Sanjiv B.
    [J]. JOURNAL OF PEDIATRICS, 2023, 254 : 91 - 95
  • [10] CONSTITUTIONAL HYPERBILIRUBINEMIA WITH UNCONJUGATED BILIRUBIN IN SERUM + PIGMENT DEPOSITION IN LIVER - REPORT OF CASE
    HERMAN, JD
    SPRINZ, H
    TAKEUCHI, A
    COOPER, EB
    [J]. AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1964, 9 (02): : 160 - &